Marc Beer

Marc Beer

Non-Executive Chairman, Former Executive Chairmanatbiote· In proxies 2023–2025

Pay in FY2025-47% from the year before · biote stock -57.9% the same year

Marc Beer was paid $1.4M in FY2025 (Dec), down 47%. biote stock fell 57.9% that year.

Pay$100 in the stock at the end of FY22 → $70
Pay is from the Summary Compensation Table of each biote proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. biotePublic company · 3 yr
    • Non-Executive Chairman, Former Executive Chairman2023 – Present · 3 yrStock in role -70%
  2. Papyrus Therapeutics Inc.Public company · 5 yr
    • Director2021 – Present · 5 yrNo stock prices for these years
  3. Origami Surgical LLCPublic company · 6 yr
    • Director2020 – Present · 6 yrNo stock prices for these years
  4. LumeNXT LLCPublic company · 8 yr
    • Director2018 – Present · 8 yrNo stock prices for these years
  5. Minerva Neurosciences, Inc.Public company · 5 yr
    • Director2013 – 2018 · 5 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?